Literature DB >> 16415936

[Advanced glycation end products and hyperglycaemia].

Tone Kristin Omsland1, Hans-Jacob Bangstad, Tore Julsrud Berg, Svein Olav Kolset.   

Abstract

Hyperglycaemia leads to increased formation and accumulation of advanced glycation end products, and these molecules play an important role in the development of micro- and macrovascular complications in diabetes. The formation of advanced glycation end products are complex reactions that take place both intra- and extracellularly. Advanced glycation end products affect gene regulation by binding to receptors, but can also modify proteins, DNA and lipids directly. The amount in serum and tissues depends upon several factors. The extent of hyperglycaemia is the main determining factor for levels of glycation products in the body, but the ability to break down and excrete these products in the urine is also important. The most effective way of preventing late complications in diabetes caused by glycation products is strict regulation of blood sugar levels. Drugs that inhibit advanced glycation end products could potentially be important in the prevention of late complications in diabetes, but this needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415936

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  3 in total

1.  The role of glycation in the pathogenesis of aging and its prevention through herbal products and physical exercise.

Authors:  Chan-Sik Kim; Sok Park; Junghyun Kim
Journal:  J Exerc Nutrition Biochem       Date:  2017-09-30

2.  Elevated advanced glycation end products are associated with subfoveal ellipsoid zone disruption in diabetic macular edema.

Authors:  Nibha Mishra; Malvika Singh; Rajendra K Singh; Sandeep Saxena
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

Review 3.  Mechanism of inflammatory response in associated comorbidities in COVID-19.

Authors:  Thays Maria Costa de Lucena; Ariane Fernandes da Silva Santos; Brenda Regina de Lima; Maria Eduarda de Albuquerque Borborema; Jaqueline de Azevêdo Silva
Journal:  Diabetes Metab Syndr       Date:  2020-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.